The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid
dc.contributor.author | Zhu R. | |
dc.contributor.author | Kiser J.J. | |
dc.contributor.author | Seifart H.I. | |
dc.contributor.author | Werely C.J. | |
dc.contributor.author | Mitchell C.D. | |
dc.contributor.author | D'Argenio D.Z. | |
dc.contributor.author | Fletcher C.V. | |
dc.date.accessioned | 2012-04-20T07:09:22Z | |
dc.date.available | 2012-04-20T07:09:22Z | |
dc.date.issued | 2012 | |
dc.description.abstract | The roles of the NAT2 genotype and enzyme maturation on isoniazid pharmacokinetics were investigated in South African infants with perinatal HIV exposure enrolled in a randomized, double-blind, controlled trial of isoniazid for prevention of tuberculosis disease and latent infection. Plasma concentration-time measurements of isoniazid from 151 infants (starting at 3-4 months of age) receiving isoniazid 10 to 20 mg/kg/d orally during the course of the 24-month study were incorporated in a population analysis along with NAT2 genotype, body weight, age, and sex. The results showed a different NAT2 enzyme maturation profile for each of the 3 acetylation groups, with the 70-kg body weight-normalized typical apparent clearance for the fast and intermediate acetylators increasing from 14.25 L/h and 10.88 L/h at 3 months of age to 22.84 L/h and 15.58 L/h at 24 months of age, respectively, with no significant change in the apparent clearance of the slow group during this period. A hypothesis is proposed to explain the genotype-dependent enzyme maturation processes for the NAT2 enzyme. © 2012 The Author(s). | |
dc.identifier.citation | Journal of Clinical Pharmacology | |
dc.identifier.citation | 52 | |
dc.identifier.citation | 4 | |
dc.identifier.citation | 511 | |
dc.identifier.citation | 519 | |
dc.identifier.issn | 912700 | |
dc.identifier.other | 10.1177/0091270011402826 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/20791 | |
dc.subject | enzyme maturation | |
dc.subject | genetic polymorphism | |
dc.subject | Infants | |
dc.subject | pharmacogenetics | |
dc.subject | population pharmacokinetics | |
dc.title | The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid | |
dc.type | Article |